Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transient assembly of precision-tuned platinum-skin intermetallic catalysts for fuel cells.

Science (New York, N.Y.)·2026
Same author

Chronic refractory ulcer caused by Edwardsiella tarda: a case report and literature review.

BMC infectious diseases·2026
Same author

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same author

Validation and application of automated CT analysis to musculoskeletal profiling in MVC occupants.

Traffic injury prevention·2026
Same author

False-positive beta-glucan test due to beta-glucan component in sterile gauze during treatment of fungal sepsis: a case report.

Frontiers in surgery·2026
Same author

PLXNA3 is overexpressed and promotes cell proliferation and migration in colorectal cancer.

Discover oncology·2026

Related Experiment Video

Updated: May 31, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.8K

Supervised Functional Principal Component Analysis Under the Mixture Cure Rate Model: An Application to Alzheimer'S

Jiahui Feng1, Haolun Shi1, Da Ma2

  • 1Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada.

Statistics in Medicine
|January 24, 2025
PubMed
Summary

This study introduces a new method to analyze brain imaging data for predicting Alzheimer's disease (AD) risk. It improves predictions by accounting for patients unlikely to develop AD and handling censored data.

Keywords:
functional principal component analysisimage analysissurvival analysistriangulation

More Related Videos

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Related Experiment Videos

Last Updated: May 31, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.8K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Area of Science:

  • Neuroimaging
  • Biostatistics
  • Medical data analysis

Background:

  • Brain imaging is crucial for Alzheimer's disease (AD) risk assessment.
  • Existing models often fail to account for patients with very low AD risk (cure fraction).
  • Right-censored time-to-event data is common in AD progression studies.

Purpose of the Study:

  • To extract image-based features for predicting time-to-event outcomes in AD.
  • To develop a statistical model that incorporates a cure fraction for AD risk.
  • To enhance predictive performance using novel feature extraction techniques.

Main Methods:

  • Introduction of a functional mixture cure rate model extending the proportional hazards model.
  • Proposal of a supervised functional principal component analysis (sFPCA) for image feature extraction.
  • Accommodation of irregular brain image boundaries using bivariate splines over triangulations.

Main Results:

  • The proposed sFPCA method effectively extracts AD risk-associated image features.
  • The functional mixture cure rate model improves prediction accuracy by considering a cure fraction.
  • The method demonstrates robustness and advantages in simulation studies.

Conclusions:

  • The novel sFPCA and functional mixture cure rate model offer a powerful approach for AD risk prediction using brain imaging.
  • Accounting for a cure fraction and handling censored data are critical for accurate AD prognostication.
  • The method shows promise for application in real-world datasets like the Alzheimer's Disease Neuroimaging Initiative (ADNI).